- Home
- MNOV vs STIM Comparison
MNOV vs STIM Comparison
Compare MNOV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- STIM
- Stock Information
- Founded
- MNOV 2000
- STIM 2003
- Country
- MNOV United States
- STIM United States
- Employees
- MNOV N/A
- STIM N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- MNOV Health Care
- STIM Health Care
- Exchange
- MNOV Nasdaq
- STIM Nasdaq
- Market Cap
- MNOV 65.7M
- STIM 224.8M
- IPO Year
- MNOV 2005
- STIM 2018
- Fundamental
- Price
- MNOV $1.23
- STIM $2.81
- Analyst Decision
- MNOV Strong Buy
- STIM Strong Buy
- Analyst Count
- MNOV 2
- STIM 2
- Target Price
- MNOV $7.00
- STIM $7.00
- AVG Volume (30 Days)
- MNOV 64.6K
- STIM 1.6M
- Earning Date
- MNOV 11-12-2025
- STIM 11-11-2025
- Dividend Yield
- MNOV N/A
- STIM N/A
- EPS Growth
- MNOV N/A
- STIM N/A
- EPS
- MNOV N/A
- STIM N/A
- Revenue
- MNOV $134,599.00
- STIM $111,106,000.00
- Revenue This Year
- MNOV N/A
- STIM $105.70
- Revenue Next Year
- MNOV N/A
- STIM $11.77
- P/E Ratio
- MNOV N/A
- STIM N/A
- Revenue Growth
- MNOV N/A
- STIM 54.17
- 52 Week Low
- MNOV $1.13
- STIM $0.52
- 52 Week High
- MNOV $2.55
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- MNOV 38.47
- STIM 46.97
- Support Level
- MNOV $1.25
- STIM N/A
- Resistance Level
- MNOV $1.38
- STIM $3.71
- Average True Range (ATR)
- MNOV 0.05
- STIM 0.24
- MACD
- MNOV -0.01
- STIM -0.14
- Stochastic Oscillator
- MNOV 4.76
- STIM 75.61
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.